Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8389076rdf:typepubmed:Citationlld:pubmed
pubmed-article:8389076lifeskim:mentionsumls-concept:C0376325lld:lifeskim
pubmed-article:8389076lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:8389076lifeskim:mentionsumls-concept:C1136102lld:lifeskim
pubmed-article:8389076lifeskim:mentionsumls-concept:C1513803lld:lifeskim
pubmed-article:8389076lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8389076pubmed:issue2lld:pubmed
pubmed-article:8389076pubmed:dateCreated1993-6-25lld:pubmed
pubmed-article:8389076pubmed:abstractTextThe VP4 capsid protein of several picornaviruses has been shown to be myristoylated at an N-terminal glycine residue. Myristoylation occurs after removal of an initial methionine residue or a leader peptide, resulting in the exposure of an N-terminal eight amino acid myristoylation signal including a consensus G-x-x-x-T/S motif. Analysis of the amino acid sequence of hepatitis A virus (HAV) capsid protein reveals a potential myristoylation site beginning at position 5 of the VP4 sequence. To assess the significance of this apparent myristoylation signal, mutations were engineered (G to A; T to N) to alter the consensus sequence as well as the potential cleavage site that would be required to remove the short leader. An additional mutant was constructed in which the proposed leader was deleted. Expression of these HAV sequences in BS-C-1 cells showed that leader cleavage did not occur in the wild-type or mutant proteins, although the threonine to asparagine mutation resulted in reduced translation and processing efficiency. Transfection of BS-C-1 or FRhK-4 cells with transcripts derived from the wild-type or mutagenized cDNA clones gave rise to infectious virus, with no detectable incorporation of myristate. The results indicate that HAV does not require leader cleavage and myristoylation of VP4 for growth in cultured cells.lld:pubmed
pubmed-article:8389076pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:languageenglld:pubmed
pubmed-article:8389076pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:citationSubsetIMlld:pubmed
pubmed-article:8389076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8389076pubmed:statusMEDLINElld:pubmed
pubmed-article:8389076pubmed:monthJunlld:pubmed
pubmed-article:8389076pubmed:issn0042-6822lld:pubmed
pubmed-article:8389076pubmed:authorpubmed-author:SummersD FDFlld:pubmed
pubmed-article:8389076pubmed:authorpubmed-author:EhrenfeldEElld:pubmed
pubmed-article:8389076pubmed:authorpubmed-author:TesarMMlld:pubmed
pubmed-article:8389076pubmed:authorpubmed-author:JiaX YXYlld:pubmed
pubmed-article:8389076pubmed:issnTypePrintlld:pubmed
pubmed-article:8389076pubmed:volume194lld:pubmed
pubmed-article:8389076pubmed:ownerNLMlld:pubmed
pubmed-article:8389076pubmed:authorsCompleteYlld:pubmed
pubmed-article:8389076pubmed:pagination616-26lld:pubmed
pubmed-article:8389076pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:meshHeadingpubmed-meshheading:8389076-...lld:pubmed
pubmed-article:8389076pubmed:year1993lld:pubmed
pubmed-article:8389076pubmed:articleTitleAnalysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.lld:pubmed
pubmed-article:8389076pubmed:affiliationDepartment of Molecular Biology and Biochemistry, University of California, Irvine 92717.lld:pubmed
pubmed-article:8389076pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8389076pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8389076pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8389076lld:pubmed